免費咨詢(xún)熱線(xiàn)：
15522676233
維奈妥拉 Venetoclax Venetoclax, also known as ABT-199 or GDC0199, is an orally bioavailable, selective small molecule inhibitor of the anti-apoptotic protein Bcl-2, with potential antineoplastic activity.
更新時(shí)間：2023-07-12
廠(chǎng)商性質(zhì)：代理商
勞拉替尼 Lorlatinib Lorlatinib, also known as PF-06463922, is an orally available, ATP-competitive inhibitor of the receptor tyrosine kinases, anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (Ros1)
更新時(shí)間：2023-07-12
廠(chǎng)商性質(zhì)：代理商
塞瑞替尼 Ceritinib Ceritinib, also known as LDK378, is a selective inhibitor of ALK1, a target found in metastatic non-small cell lung cancer (NSCLC).
更新時(shí)間：2023-07-12
廠(chǎng)商性質(zhì)：代理商
布格替尼 Brigatinib Brigatinib, also known as AP-26113, is an orally active, potent and selective Dual ALK/EGFR inhibitor.
更新時(shí)間：2023-07-12
廠(chǎng)商性質(zhì)：代理商
艾樂(lè )替尼 Alectinib Alectinib, also known as AF802, or CH5424802 or RO5424802, is a potent, selective, and orally available ALK inhibitor with a unique chemical scaffold
更新時(shí)間：2023-07-12
廠(chǎng)商性質(zhì)：代理商
微信掃一掃
